Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the Company's patented and proprietary BIOREACTANCE technology. Clinicians use the NICOM for noninvasive, Goal Directed Fluid Management in critical and non-critical clinical environments. NICOM is FDA cleared and has received a CE Mark.
Market
Healthcare
Location
Vancouver,
WA,
USA
Coinvestors
Fletcher Spaght Ventures, HighCape Partners, MVM Partners, Robert Bosch Venture Capital, Springfield Investments